In contrast, CAF-released SDF-1, in breast cancer, binds the CXCR4 receptor on adjacent stem cells (CD44+CD24−cells), promoting their proliferation and tumor transformation [77,78]. This evidence concerns the gene CXCL12 and breast carcinoma.